Exiqon A/S (NASDAQ OMX: EXQ), a leading supplier of high-value gene expression
analysis products, today announced the launch of an additional qPCR array for
sensitive and specific quantification of 749 mouse and rat microRNAs.

With the launch of the new rodent qPCR array, Exiqon now offers two qPCR arrays
for mouse and rat microRNAs in addition to the two qPCR arrays for human
microRNAs. All qPCR arrays are based on LNA™ enhanced microRNA PCR primer sets
and comprise more than 1,500 pre-validated assays making the qPCR assay
offering the most comprehensive in the market.

“We have seen an increasing demand for a second mouse and rat qPCR array for
genome wide screening and we are happy to have this product on the market
today” said Senior Vice President Sales & Marketing, Dr. Henrik M. Pfundheller
and added: “All assays are validated against synthetic miRNA targets and tested
for specificity and linear dynamic range of a minimum of 5 logs”.

The extreme sensitivity obtained by inclusion of LNA™ in the PCR primers
enables accurate microRNA profiling based on as little as 50 µl serum.

Exiqon's product line for microRNA qPCR also includes custom Pick & Mix
ready-to-use 96- and 384-well panels, individual pre-validated and custom
designed primer sets as well as RT and Master Mix kits and a qPCR data analysis
software package.

Please see the full press release in the enclosed pdf-file.

Additional information:

Lars Kongsbak, President and CEO, tel. +45 4566 0888 (cell: +45 4090 2101)

Henrik M. Pfundheller, SVP Sales & Marketing, tel. +45 4565 0420 (cell: +45
4090 2106)

PressRelease_May2011_Rodent_qPCR_Array.pdf